Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis-Reference-Cited by-同舟云学术

Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis

Published:2020-09 Issue:9 Volume:7 Page:749-761
ISSN:2215-0366
Container-title:The Lancet Psychiatry
language:en
Short-container-title:The Lancet Psychiatry

Author:

Rubio Jose M,Schoretsanitis Georgios,John Majnu,Tiihonen Jari,Taipale Heidi,Guinart Daniel,Malhotra Anil K,Correll Christoph U,Kane John M

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference48 articles.

1. Schizophrenia—an overview;McCutcheon;JAMA Psychiatry,2019

2. What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?;Correll;World Psychiatry,2018

3. Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies;Kane;World Psychiatry,2013

4. Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?;Rubio;NPJ Schizophr,2017

5. Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy;Alphs;Int Clin Psychopharmacol,2016

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Healthcare utilization and economics evaluation of paliperidone palmitate once-monthly in schizophrenia: a one-year, real-world, and retrospective mirror image study in China;Frontiers in Psychiatry;2024-09-04

2. Behind the heterogeneity in the long-term course of first-episode psychosis: Different psychotic symptom trajectories are associated with different patterns of cannabis and stimulant use;Schizophrenia Research;2024-09

3. Effect of Long-Term Tai Chi Therapy on the Immune-Inflammatory Pathway in Patients with Schizophrenia with Antipsychotic-Stabilized;Molecular Neurobiology;2024-08-10

4. An overview of the currently available and emerging long-acting formulations of risperidone for schizophrenia and bipolar disorder;Expert Review of Neurotherapeutics;2024-07-23

5. Three-Year Outcomes of 6-Month Paliperidone Palmitate in Adults With Schizophrenia;JAMA Network Open;2024-07-17